Molina Healthcare Inc. (MOH)
NYSE: MOH
· Real-Time Price · USD
305.08
1.21 (0.40%)
At close: May 30, 2025, 3:59 PM
305.04
-0.01%
After-hours: May 30, 2025, 04:47 PM EDT
Molina Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other Segments Revenue | 81M | 2.3B | 3.09B | 8M | 14M | 187M | 195M | 195M | 210.05M | 204.53M |
| Other Segments Revenue Growth | -96.47% | -25.72% | +38537.50% | -42.86% | -92.51% | -4.10% | 0.00% | -7.17% | +2.70% | n/a |
| Marketplace Revenue | 2.51B | 25.78B | 21.23B | n/a | n/a | 344M | 353M | 66M | n/a | n/a |
| Marketplace Revenue Growth | -90.28% | +21.44% | n/a | n/a | n/a | -2.55% | +434.85% | n/a | n/a | n/a |
| Medicaid Solutions Segment Revenue | 30.58B | 3.82B | 3.38B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medicaid Solutions Segment Revenue Growth | +699.66% | +13.17% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medicare Revenue | 5.54B | 71M | 70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medicare Revenue Growth | +7705.63% | +1.43% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 774M | 665M | 676M | 691M | 711M | 645M | 608M | 618M | 591M | 629M | 560M | 551M | 571M | 579M | 532M | 484M | 473M | 450M | 368M | 345M | 317M | 343M | 323M | 328M | 302M | 335M | 311M | 335M | 352M | 367M | 383M | 405M | 439M | 359M | 343M | 351M | 340M | 317M | 287.69M | 286.5M | 256.09M |
| Selling, General, and Administrative Revenue Growth | +16.39% | -1.63% | -2.17% | -2.81% | +10.23% | +6.09% | -1.62% | +4.57% | -6.04% | +12.32% | +1.63% | -3.50% | -1.38% | +8.83% | +9.92% | +2.33% | +5.11% | +22.28% | +6.67% | +8.83% | -7.58% | +6.19% | -1.52% | +8.61% | -9.85% | +7.72% | -7.16% | -4.83% | -4.09% | -4.18% | -5.43% | -7.74% | +22.28% | +4.66% | -2.28% | +3.24% | +7.26% | +10.19% | +0.42% | +11.87% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |